Market Overview

Inovio Pharmaceuticals Selected by DARPA to Lead a $45M Program to Expedite Development of Novel Products to Prevent, Treat Disease Caused by Ebola

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Contracts

 

Related Articles (INO)

Partner Center